Q4 2020 Holdings
Filed 2021-02-12 | 59 holdings | $112.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $30.6M | 1,400,000 | 27.2% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $29.9M | 1,662,500 | 26.7% |
| Acutus Medical Inc(AFIB) | COM | 005111109 | $21.6M | 749,990 | 19.3% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $17.4M | 992,000 | 15.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.1M | 582,800 | 10.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $134.8K | 6,510,000 | 0.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $61.9K | 2,558,472 | 0.1% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $41.5K | 315,550 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $32.8K | 4,040,000 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $29.5K | 2,518,371 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $21.7K | 350,000 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $21.0K | 3,065,416 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $20.2K | 387,500 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $20.1K | 455,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $19.5K | 1,386,300 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $19.1K | 3,956,500 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $15.4K | 3,021,436 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $12.7K | 222,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $12.3K | 3,887,500 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $10.5K | 682,500 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $10.0K | 281,287 | 0.0% |
| Seres Therapeutics(MCRB1EUR) | COM | 81750R102 | $9.8K | 335,312 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $9.8K | 114,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.9K | 470,203 | 0.0% |
| Vaxcyte(PCVX) | COM | 92243G108 | $8.9K | 335,200 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $8.5K | 370,600 | 0.0% |
| FS DEV Corp | COM CL A | 303020101 | $7.7K | 704,400 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.0K | 260,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $7.0K | 322,200 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $6.9K | 2,620,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $6.8K | 959,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $6.7K | 3,171,800 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $6.5K | 381,900 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $6.4K | 1,487,800 | 0.0% |
| Merus NV | COM | N5749R100 | $6.2K | 353,000 | 0.0% |
| SIO Gene Therapies Inc | COM | 829399104 | $5.6K | 2,000,000 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.5K | 365,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.5K | 147,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $4.8K | 2,325,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $4.1K | 1,556,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.0K | 224,100 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $3.7K | 708,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $3.5K | 800,000 | 0.0% |
| Praxis Precision Medicines Inc | COM | 74006W108 | $3.5K | 63,416 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $3.4K | 115,000 | 0.0% |
| Edap TMS SA(EDA) | SPONSORED ADR | 268311107 | $3.4K | 657,500 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $3.4K | 284,050 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $3.2K | 254,000 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $2.2K | 440,000 | 0.0% |
| Optinose Inc | COM | 68404V100 | $1.8K | 435,000 | 0.0% |